Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Samital in pediatric patients at risk of oral mucositis – feasibility study
2015-000386-31Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Samital in stomatitis, sponsored by Azienda Ospedaliero-Universitaria di Padova. Primary endpoint: Feasibility of Samital administration. Started Dec 2020; status: completed.
02
Drugs
Samital
03
Conditions
stomatitis
Beyond the preview
Go deeper on 2015-000386-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000386-31.